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ABSTRACT Induction of immunity that limits Toxoplasma gondii infection in mice is critically dependent on the activation of the
innate immune response. In this study, we investigated the role of cytoplasmic nucleotide-binding domain and leucine-rich re-
peat containing a pyrin domain (NLRP) inflammasome sensors during acute toxoplasmosis in mice. We show that in vitro Tox-
oplasma infection of murine bone marrow-derived macrophages activates the NLRP3 inflammasome, resulting in the rapid pro-
duction and cleavage of interleukin-1 (IL-1), with nomeasurable cleavage of IL-18 and no pyroptosis. Paradoxically,
Toxoplasma-infected mice produced large quantities of IL-18 but had nomeasurable IL-1 in their serum. Infection of mice de-
ficient in NLRP3, caspase-1/11, IL-1R, or the inflammasome adaptor protein ASC led to decreased levels of circulating IL-18, in-
creased parasite replication, and death. Interestingly, mice deficient in NLRP1 also displayed increased parasite loads and acute
mortality. Using mice deficient in IL-18 and IL-18R, we show that this cytokine plays an important role in limiting parasite repli-
cation to promote murine survival. Our findings reveal T. gondii as a novel activator of the NLRP1 and NLRP3 inflammasomes
in vivo and establish a role for these sensors in host resistance to toxoplasmosis.
IMPORTANCE Inflammasomes are multiprotein complexes that are a major component of the innate immune system. They con-
tain “sensor” proteins that are responsible for detecting various microbial and environmental danger signals and function by
activating caspase-1, an enzyme that mediates cleavage and release of the proinflammatory cytokines interleukin-1 (IL-1) and
IL-18. Toxoplasma gondii is a highly successful protozoan parasite capable of infecting a wide range of host species that have
variable levels of resistance. We report here that T. gondii is a novel activator of the NLRP1 and NLRP3 inflammasomes in vivo
and establish a role for these sensors in host resistance to toxoplasmosis. Using mice deficient in IL-18 and IL-18R, we show that
the IL-18 cytokine plays a pivotal role by limiting parasite replication to promote murine survival.
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The innate immune response plays a critical role in protectinghosts against pathogens. Activation of innate immunity occurs
after pattern recognition “sensor” proteins such as the Toll-like
receptors (TLRs) or nucleotide-binding domain and leucine-rich
repeat-containing (NLR) proteins detect the presence of patho-
gens, their products, or the danger signals that they induce during
active infection (1, 2). Toxoplasma gondii is an intracellular pro-
tozoan parasite capable of potently activating innate immunity in
the wide range of vertebrate species that it infects (3, 4). In mice,
resistance toT. gondii infection is critically dependent on the TLR-
associated adaptor protein MyD88, which is required for the in-
duction of protective levels of the proinflammatory cytokines
interleukin-12 (IL-12) and gamma interferon (IFN-) and the
synthesis of nitric oxide (NO) (5–11). The activation and recruit-
ment of inflammatory monocytes to sites of infection are protec-
tive, as infection of mice rendered deficient in Gr1 inflammatory
monocytes by antibody depletion results in increased susceptibil-
ity to parasite infection (12, 13). Furthermore, chemokine recep-
tor CCR2- and MCP1 (CCL2)-knockout (KO) mice, defective in
recruitment of these cells, are also more susceptible (12, 13).
Hence, induction of protective immunity against this protozoan
pathogen is critically dependent on monocyte and macrophage
cell activation.
Macrophages are activated when their cognate receptors detect
the presence of microbial products. In the case of cytosolic NLRs,
which sense the presence of microbes and/or the damage that their
infection induces, activation leads to the assembly of the inflam-
masome, a multiprotein complex that recruits and activates
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caspase-1 and/or caspase-11. The murine NLRP3 inflammasome
senses a wide range of bacteria, pore-forming toxins, and crystal-
line danger signals, including alum, amyloid clusters, cholesterol,
and asbestos (for a review, see reference 14). In contrast, the mu-
rine NLRP1b inflammasome is more restricted; the only charac-
terized activator is the Bacillus anthracis lethal toxin (LT) (15).
Either multimeric complex is capable of cleaving the proform of
caspase-1, which is typically associated with the rapid death of
macrophages, through a process known as pyroptosis (for a re-
view, see references 1 and 2). Pyroptosis, unlike apoptosis, leads to
lysis of the cell and release of its intracellular contents. Caspase-1
also cleaves the proinflammatory cytokines IL-1 and IL-18, al-
lowing their secretion from cells (for a review, see references 1 and
2). Whether the inflammasome is activated during Toxoplasma
infection, or is capable of altering disease pathogenesis, has thus
far been only inferred. An association of polymorphisms in the
humanNlrp1 gene with susceptibility to congenital toxoplasmosis
was recently reported (16, 17). T. gondii production of cleaved
IL-1 in human monocytes is dependent on both caspase-1 and
the NLRP3 adaptor protein ASC (18). P2X(7) receptors, which are
important in ATP-mediated activation of the NLRP3 inflam-
masome, have also been shown to influence parasite proliferation
in human and murine cells (19). IL-18, a key substrate of
inflammasome-activated caspase-1, is known to enhance produc-
tion of IFN- (20), which is a central regulator of Toxoplasma
pathogenesis. Furthermore, in vivo administration of IL-1 pro-
tects mice from lethal challenge with Toxoplasma (21) and injec-
tion of antibodies against the IL-1 receptor (IL-1R) significantly
attenuates the protective effect that exogenous IL-12 confers on
infected SCID mice (22). Thus, we hypothesized that inflam-
masome activation might be an important factor mediating mu-
rine host resistance to Toxoplasma infection.
In this study, we show that murine macrophages are not sus-
ceptible to T. gondii-induced rapid pyroptosis but that NLRP3
inflammasome activation in these cells results in rapid IL-1
cleavage and release. We establish that both NLRP3 and NLRP1
are important in vivo regulators of parasite proliferation and that
IL-18 signaling is required to mediate host resistance to acute
toxoplasmosis. Our findings establish a role for two inflam-
masomes in the control of Toxoplasma infection.
RESULTS
Toxoplasma activates the inflammasome in murine macro-
phages without inducing cell death. Induction of protective im-
munity capable of controlling murine Toxoplasma infection is
critically dependent on myeloid cell activation (3). The ability of
this parasite to promote caspase-1 activation and the secretion of
active IL-1 has recently been established in human and rat
monocytes and macrophages (17, 18, 66). To determine if Toxo-
plasma activates the inflammasome in murine macrophages, we
infected unstimulated and lipopolysaccharide (LPS)-primed
bone marrow-derived macrophages (BMDMs) prepared from
C57BL/6J mice with type II (Pru) parasites and measured IL-1
secretion 24 h after infection (Fig. 1A). Uninfected BMDMs did
not produce measurable levels of IL-1 (Fig. 1A), whereas IL-1
was readily detected after infection with type II Toxoplasma re-
gardless of whether the BMDMs were LPS primed or not (Fig. 1A).
Western blotting of infected BMDM lysates showed the presence
of mature IL-1 and showed that cleavage was dependent on
caspase-1/11, since infected BMDMs from caspase-1/11-deficient
mice did not possess detectable levels of cleaved IL-1 (Fig. 1B).
The detection of mature IL-1 in the Toxoplasma-infected
BMDMs indicated inflammasome activation, but the cells did not
undergo pyroptosis over 24 h (Fig. 1C). These data support an
inflammasome-mediated processing and release of mature IL-1
in the absence of pyroptosis, which have been demonstrated to
occur previously (23). Interestingly, IL-18 upregulation and
cleavage were not observed in Toxoplasma-infected BMDM or
splenocyte lysates over a range of multiplicities of infection
(MOIs) and times, and the cytokine was not released from in
vitro-infected macrophages or splenocytes (data not shown).
Because IL-1 secretion was consistently dependent on MOI
(data not shown), we tested whether parasite invasion was re-
quired for IL-1 secretion. Parasites pretreated with mycalolide B,
an actin-depolymerizing agent that blocks invasion but allows for
secretion of microneme and rhoptry contents, attached but in-
duced significantly smaller amounts of IL-1 secretion (Fig. 1D),
indicating that macrophage inflammasome activation was inva-
sion dependent. The small amount of IL-1 secretion by BMDMs
infected by mycalolide B-treated parasites was likely due to in-
complete inhibition of invasion, as immunofluorescence micros-
copy performed on the same batch of treated parasites indicated
that a small number had still invaded the BMDMs, as evidenced by
their intracellular replication (data not shown).
IL-1 secretion correlates with strain differences in NF-B
activation. Mouse strains differ in their susceptibility to Toxo-
plasma depending on the infecting strain genotype; haplogroup 2
and 12 (HG2 and HG12) strains are relatively avirulent and read-
ily establish chronic infections, whereas HG1 and HG4 to HG10
strains are acutely virulent. We sought to determine whether Tox-
oplasma strains differentially activate the murine macrophage in-
flammasome, or whether secretion of IL-1 correlated with par-
asite genotype and/or pathogenesis. We infected unprimed
BMDMs from C57BL/6J mice with Toxoplasma tachyzoites from
all 12 haplogroups for 24 h, a time point at which parasite-induced
cell lysis was minimal. Cougar (HG11) and the type II strains, with
the exception of DEG, induced IL-1 secretion in unstimulated
BMDMs (Fig. 1E). Inflammasome activation is often divided into
a signal 1, which is the signal that leads to transcription of Il-1,
and signal 2, which is the signal that leads to the actual activation
of caspase-1. Type II, but not type I or III, parasites directly acti-
vate the NF-B transcription factor in both human and murine
cells, thereby potentially providing signal 1 for the induction of
Il-1 transcription. The secreted dense granule protein GRA15
determines this strain difference in NF-B activation (24). Indeed,
in murine BMDMs, type II IL-1 mRNA induction was partially
dependent on type II GRA15 expression (Fig. 1F), while IL-1
secretion of unstimulated BMDMs was completely dependent on
GRA15 (Fig. 1G). To determine if non-type II strains can provide
signal 2, which leads to the activation of caspase-1 and subsequent
cleavage and secretion of IL-1, we prestimulated BMDMs with
LPS for 2 h and subsequently infected them with different Toxo-
plasma strains. IL-1 was now detected in the medium with no
truly apparent differences between strains (Fig. 1H). The IL-1
secreted into the medium also contained the cleaved active IL-1
(17 kDa) as determined by Western blot analysis (see Fig. S2 in the
supplemental material).
Toxoplasma activation of the murine inflammasome in
BMDMs is dependent on caspase-1/11 and NLRP3. To deter-
mine the components necessary for IL-1 secretion, we infected
Gorfu et al.
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FIG 1 Toxoplasma activates the inflammasome in C57BL/6 and 129S BMDMs. BMDMs were primed with 100 ng/ml LPS or left unstimulated for 2 h and
subsequently infected with type II parasites (Pru; average MOI, 1) for 24 h. (A) Quantification of IL-1 in supernatants was performed using ELISA. (B) IL-1
cleavage was monitored by Western blotting of cell lysates from C57BL/6NTac or caspase-1/11/ BMDMs that were infected with type II parasites (Pru; MOI,
0.8) for 24 h. The positions of both pro-IL-1 (37 kDa) and cleaved IL-1 (17 kDa) are indicated. (C) Cell viability of infected cells in panel A was determined
at different time points using an MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay. Panels A and C are
averages of three experiments. Error bars,standard deviations. (D) BMDMs were primed with LPS for 2 h and infected for 24 h with type I parasites (RH) that
were pretreated with dimethyl sulfoxide vehicle or mycalolide B (3M) for 20 min. IL-1was measured using ELISA. Data are averages of 2 experiments. Error
bars,standard deviations. (E) C57BL/6 BMDMs were infected with the indicated strains for 24 h. IL-1was measured using ELISA. Data are the averages of at
(Continued)
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immortalized macrophages that lacked caspase-1 and -11 and
showed that IL-1 secretion was completely eliminated, as ex-
pected (Fig. 1I). To determine the inflammasome components
necessary for IL-1 secretion, we infected BMDMs from C57BL/6
mice that lacked Nlrp1b, Nlrp3, or both Nlrp1b and Nlrp3, or the
inflammasome adaptor ASC. We found IL-1 secretion by
primed BMDMs upon Toxoplasma type I infection to be mostly
dependent on ASC and the NLRP3 inflammasome (Fig. 1J). Sim-
ilar results were obtained after type II infection (see Fig. S3 in the
supplemental material). The greatly reduced amount of cleaved
active IL-1 in the supernatant of Nlrp3-deficient Toxoplasma-
infected BMDMs compared to the amount present in the super-
natant of wild-type (WT) or Nlrp1b-deficient infected BMDMs
confirmed the importance of the NLRP3 inflammasome in
Toxoplasma-mediated inflammasome activation in vitro (Fig. 1K).
Thus, Toxoplasma induction of IL-1 secretion by murine
BMDMs is highly dependent on the NLRP3 inflammasome and
requires caspase-1 activation.
Inflammasome-mediated BMDM death and cytokine pro-
cessing are independent of Nlrp1a and Nlrp1b alleles. Despite
the activation of caspase-1 in Toxoplasma-infected cells, we did
not observe any macrophage pyroptosis. Previous reports have
shown that five polymorphic Nlrp1b alleles exist among inbred
mice which control sensitivity to anthrax LT-induced pyroptosis
(15). To test if the 100-amino-acid (aa) differences in Nlrp1b
between C57BL/6J and 129S mice were the basis for resistance to
parasite-induced pyroptosis, we compared BMDMs from the two
strains. We observed no difference in cell viability between the
C57BL/6J and 129S BMDMs (Fig. 1L). Thus, consistent with a
major role for NLRP3 inflammasome activation, BMDMs from
either 129S or C57BL/6 mice produced active IL-1 (Fig. 1M and
N) without associated pyroptosis upon type I or II Toxoplasma
strain infection. Furthermore, the fact that 129S BMDMs do not
express the highly conserved NLRP1a protein (25) and are
caspase-11 deficient (26) but present a robust IL-1 response also
eliminated a role for NLRP1a and caspase-11 in cytokine matura-
tion induced by Toxoplasma.
Murine resistance to Toxoplasma infection is controlled by
caspase-1/11-dependent inflammasome activation.Whether in-
flammasome activation is important to murine resistance to in-
fection in vivo has not yet been established. We infected mice
deleted for the caspase-1/11 genes with 10,000 type II 76K green
fluorescent protein-luciferase (GFP-LUC) tachyzoites intraperi-
toneally (i.p.) and tested for susceptibility to acute infection by
monitoring mean survival time (MST), parasite growth, dissemi-
nation, and the production of IL-1 and IL-18. In the absence of
caspase-1/11 proteins, mice had a 10- to 20-fold-higher parasite
load (Fig. 2A and B) and were highly susceptible to acute infection
(Fig. 2C). In contrast, the majority of C57/BL6NTac control mice
survived acute infection and established chronic infections
(Fig. 2C). Surprisingly, serum levels of systemic IL-1 never ex-
ceeded 10 pg/ml on day 5 (Fig. 2D, graph on left) or day 9 (data not
shown) for either mouse strain. IL-18 levels, however, were signif-
icantly higher following infection, ranging from 0.5 to 2.0 ng/ml in
C57BL/6NTac mice on day 5 (Fig. 2D), to strikingly high levels
exceeding 10 ng/ml by day 9, compared to200 pg/ml in caspase-
1/11-deficient mice (Fig. 2D) or uninfected controls (data not
shown).
ASC and NLRP3 inflammasome activation controls Toxo-
plasma proliferation and host resistance. We next investigated
the role of ASC in murine susceptibility to Toxoplasma infection,
since this adaptor protein is required to mediate the activation of
multiple inflammasomes (27). If inflammasome activation con-
trols Toxoplasma resistance, we hypothesized that mice rendered
deficient in this protein will be more susceptible to acute infection.
Asc-deficient mice consistently had ~20-fold or greater parasite
loads at days 5 to 7 postinfection (Fig. 3A and B) and generally
succumbed to infection by days 8 to 10 (Fig. 3C), in contrast to
wild-type control mice, the majority of which survived acute in-
fection at day 20 (Fig. 3C). The Asc-deficient mice likewise failed
to induce detectable levels of systemic IL-18 (Fig. 3D) or IL-1
(data not shown) during acute infection.
To determine whether the NLRP3 inflammasome sensor is suf-
ficient to confer this murine resistance to the Toxoplasma pheno-
type, Nlrp3/ mice on the C57BL/6J background were infected
intraperitoneally with 10,000 76K GFP-LUC tachyzoites.
Nlrp3/ mice were more susceptible than their wild-type (WT)
controls and possessed 10-fold or higher parasite burdens at days
5 to 7, and the majority of mice died by day 10 postinfection
(Fig. 3C). These infected mice produced intermediate levels of
systemic IL-18, significantly greater than those of theAsc-deficient
mice but not equivalent to those of the WT (Fig. 3D). They did not
produce measurable levels of IL-1 (data not shown), similar to
what was observed with all infections of WT mice (Fig. 2D and
data not shown). Infection with another type II strain (Pru GFP-
LUC) produced similar results (data not shown), indicating that
the phenotype was not attributable to an anomalous Toxoplasma
clone-specific effect or the genome integration site of the GFP-
Figure Legend Continued
least 3 experiments per strain. The haplogroup to which the strain belongs is indicated above. Error bars, standard deviations. (F) C57BL/6 BMDMs were
infected for 18 h with Pru (type II) or PruGRA15 (MOI, 4) for 18 h, and microarrays were used to determine the fold change in IL-1mRNA expression levels
compared to uninfected macrophages. (G) BMDMs were infected with Pru (type II) or PruGRA15 for 24 h. IL-1 was measured using ELISA. Data are
representative of 3 experiments. Error bars,standard deviations. (H) BMDMs were primed for 2 h with LPS and then infected with indicated strains for 24 h
(MOI, 4). The haplogroup to which the strain belongs is indicated above. Data are the averages of 3 experiments. Error bars,standard deviations. (I) IL-1
secretion from primed immortalized murine WT and caspase-1/11/ macrophages, infected for 24 h with RH. Data shown are from an experiment represen-
tative of three. Error bars, standard deviations. (J) IL-1 secretion from BMDMs prepared from wild-type C57BL/6 mice (blue) or C57BL/6 mice lacking
Nlrp1b (red), Nlrp3 (green), Nlrp1b and Nlrp3 (orange), or Asc (yellow), primed for 4 h, and then infected with type I (RH; average MOI, 1) for 24 h. Cytokine
secretion below the detection level is indicated on the graph with arrowheads and labeled not detected (n.d.). Data are averages of four experiments. Error bars,
standard deviations. (K) BMDMs described for panel J were primed for 3 h with LPS and then infected with type II parasites (MOI, 1.5) for 24 h. Western blot
analysis on concentrated supernatants (25-fold), probing for cleaved IL-1 (17 kDa). (L) Host cell viability in panel L was measured using the MTS assay. Error
bars,standard deviations. (M) BMDMs from C57BL/6 and 129S mice were primed with 100 ng/ml LPS for 2 h and subsequently infected with type II parasites
(Pru; average MOI, 0.7) for 24 h. Quantification of IL-1 in supernatants was performed using ELISA. Panels L and M are the averages of 3 experiments. (N) 129S
BMDMs were primed for 2 h and infected with type II parasites (MOI, 1.6) for 24 h. Western blot analysis on concentrated supernatants (25-fold), probing for
cleaved IL-1 (17 kDa). Nig, nigericin; Tg, T. gondii.
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LUC gene, as both type II strains activated the inflammasome in
vivo. These results indicate that murine resistance to acute infec-
tion with Toxoplasma is highly dependent on the activation of the
NLRP3 inflammasome.
NLRP1 inflammasome activation also controls Toxoplasma
proliferation and host resistance. Because the infected Nlrp3-
deficient mice still produced IL-18 at levels higher than those of
Asc-deficient mice, we hypothesized that more than one inflam-
masome is activated in vivo to produce IL-18 during Toxoplasma
infection. To test this prediction, we infected mice deficient at the
Nlrp1 locus encompassing Nlrp1abc with 10,000 76K GFP-LUC
tachyzoites to determine if NLRP1 activation contributes to mu-
rine resistance during Toxoplasma infection. Nlrp1abc-deficient
mice had only 3- to 5-fold-higher parasite loads than did WT mice
across days 5 to 7 (Fig. 4B). Nlrp1abc/ mice also died acutely,
succumbing to infection between days 16 and 22 (Fig. 4C). The
delayed MST kinetics was consistent with the decreased parasite
burden in comparison to the Nlrp3-deficient mice. Nlrp1abc-
deficient mice produced intermediate levels of systemic IL-18, sig-
nificantly greater than those of the Asc-deficient mice but not
equivalent to those of the WT (Fig. 4D). No measurable levels of
circulating IL-1were found on day 5 or 9 after infection in these
mice or their WT controls (data not shown).
Mice deficient in signaling and secretion of IL-18 are highly
susceptible to Toxoplasma infection. Although no systemic
IL-1 was detectable in vivo, infection of NLRP3-deficient
BMDMs showed markedly diminished levels of IL-1 (Fig. 1). To
test if IL-1 possesses a biologically important role locally and is
capable of influencing murine resistance, we infected IL-1R/
mice with 10,000 76K GFP-LUC tachyzoites. All IL-1R-deficient
mice succumbed to infection but with a delayed kinetics com-
pared to ASC-, caspase-1/11-, and Nlrp3-deficient mice (Fig. 5C).
These mice supported higher parasite loads and had intermediate
levels of IL-18 in their serum compared to WT C57BL6/J mice
(Fig. 5A, B, and D), indicating that despite the absence of measur-
able IL-1 in circulation, IL-1 signaling does play a contributing
role in the protection against murine toxoplasmosis.
Intriguingly, the level of IL-18 in the circulation of infected WT
mice correlated with decreased parasite burden and increased sur-
vival. We hypothesized that inflammasome activation and the
production of high systemic IL-18 might play an important role in
the relative resistance of WT mice. To test our hypothesis, we
FIG 2 Parasite load, survival, and systemic IL-18 levels in caspase-1/11-deficient mice. (A) Bioluminescence imaging (BLI) of infected caspase-1/11 knockouts
and controls on days 5 to 7 following infection with 76K GFP-LUC (10,000 tachyzoites i.p.). Images shown are for 3 mice. (B) Quantifications are from 8 mice
imaged/group. (C) Aggregate survival of caspase-1/11-knockout mice (n 13/group) compared with WT C57BL/6NTac control mice (n 10/group). (D) IL-18
measurements in serum of caspase-1/11-deficient mice on day 5 after infection were significantly different from WT (P  0.001) when infected with 76K
GFP-LUC. No detectable levels of IL-1 were detected in circulation.
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infected IL-18/ and IL-18R/ mice. Both types of mice were
highly susceptible to acute Toxoplasma infection and consistently
had 20- to 100-fold-increased parasite loads at days 5 to 7
postinfection, greater than that found in the Asc/mice (Fig. 5A
and B). These mice typically succumbed to infection by day 8 or 9
(Fig. 5C), suggesting that the presence of IL-18 is protective in
C57BL/6 mice. These data indicate that the production and secre-
tion of activated IL-18 are associated with controlling parasite
proliferation and murine resistance to acute toxoplasmosis.
DISCUSSION
Generation of a robust innate immune response is required to
orchestrate murine resistance against the intracellular pathogen
T. gondii, as well as a wide spectrum of other pathogenic agents
(for a review, see reference 3). Resistance to Toxoplasma infection
is critically dependent on the TLR-associated adaptor protein
MyD88 and induction of IL-12, IFN-, and the synthesis of nitric
oxide (NO). In this study, we show that in vivo generation of host
protective immunity against Toxoplasma is also highly dependent
on the inflammasome sensors NLRP1 and NLRP3 and the secre-
tion of the caspase-1-dependent proinflammatory cytokine IL-18.
Infection of mice deficient in NLRP3, NLRP1abc, caspase-1/11, or
the inflammasome adaptor protein ASC led to decreased levels of
circulating IL-18, increased parasite replication, and death. Using
mice deficient in IL-18 and IL-18R, we show that this cytokine
plays an important role in limiting parasite replication to promote
murine survival.
IL-18, like IL-1, has been extensively linked to both protective
immune responses and disease induction. IL-18 mediates en-
hancement of innate resistance to acute toxoplasmosis by trigger-
ing IFN- induction in immune cells, especially T and NK cells,
and works in synergy with IL-12. It has previously been used as a
protective treatment (28, 29), and IL-18 depletion by antibodies
significantly alters murine susceptibility upon infection with le-
thal doses of Toxoplasma (30). In fact, IL-18 was at one time
known as “IFN--inducing factor” (31). The inactive pro-IL-18
form is constitutively expressed in a wide range of cell types (32)
but requires processing by caspase-1 to promote its secretion, as
FIG 3 Parasite load, survival, and systemic IL-18 levels in ASC- and NLRP3-knockout mice following Toxoplasma challenge. (A) Bioluminescence imaging of
76K GFP-LUC-infected mice (various strains, 10,000 tachyzoites, i.p. route) on days 5 to 7 following infection is shown. Images shown are from two or three
representative mice from 2 to 6 mice/group from one representative experiment. The experiment shown is one of 3 (WT) or 2 (ASC and NLRP3) independent
experiments. (B) P values (t test) comparing luciferase activity for each knockout strain to C57BL/6J are0.05. (C) Aggregate survival curve of ASC (n 8)- and
NLRP3 (n 5)-knockout mice compared with WT C57BL/6J control mice (n 13). (D) IL-18 measurements in serum of deficient mice on day 5 after infection.
No detectable levels of IL-1 were detected in circulation.
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evidenced by the drastically depleted levels of IL-18 during infec-
tion of caspase-1/11/ mice (Fig. 2D), and promote the induc-
tion of IFN- production in vivo (33, 34). Interestingly, Asc-
deficient mice produced even less circulating IL-18, indicating
that other factors such as caspase-8 (35) may contribute to IL-18
processing.
The role of IFN- in resistance to Toxoplasma is extensively
documented (for a review, see references 3 and 4). IFN- activates
cellular pathways that promote resistance to toxoplasmosis
through multiple mechanisms, including activation of the
interferon-inducible GTPases (IRG-GTPases) (36, 37) and NO
regulation (9), processes certainly dependent on induction of
IFN- by IL-18 produced following NLR inflammasome activa-
tion. However, IL-18 has also been linked to pathology during
infection with type I strains of Toxoplasma, and IL-18 depletion
resulted in enhanced survival by limiting the propathologic im-
mune response that these virulent strains induce (30, 38). Hence,
the balance between the protective and pathological roles of IL-18
is likely highly dependent on mouse genetics, Toxoplasma strain
differences, challenge doses, routes of infection, and rates of dis-
ease progression. Previous work using a low-dose type II (PTG)
infection in caspase-1-deficient mice (now known to be caspase-
1/11 deficient) concluded that these mice were not altered in Tox-
oplasma susceptibility relative to wild-type control mice (39).
However, this study was performed with a parasite dose that does
not typically induce measurable levels of systemic IL-18 (30), and
the mice used had a mixed 129/B6 background, which itself may
influence pathogenesis. Our results, using mice sufficiently back-
crossed onto a C57BL/6NTac background and a parasite inocu-
lum that induces systemic IL-18, show a role for caspase-1 and
IL-18 in murine resistance. IL-18 concentrations are known to
vary through the course of infection and are clearly dependent on
the parasite strain and inoculum used (30, 38). Our results suggest
that this cytokine plays a pivotal role in mediating acute toxoplas-
mosis, with the cytokine playing an important early role in the
control of parasite replication (Fig. 5B). How exactly IL-18 medi-
ates this protection requires further studies. Later in infection,
however, high levels of IL-18 have previously been shown to cause
FIG 4 Parasite load, survival, and systemic IL-18 levels in NLRP1-knockout mice following Toxoplasma challenge. (A) Bioluminescence imaging of 76K
GFP-LUC-infected mice (various strains, 10,000 tachyzoites, i.p. route) on days 5 to 7 following infection is shown. Images shown are three representative mice
from 4 to 6 mice/group from one representative experiment. The experiment shown is one of 2 WT or 2 NLRP1 independent experiments. (B) P values (t test)
comparing luciferase activity for each knockout strain to C57BL/6NTac are0.05. (C) Aggregate survival curve of NLRP1 (n 10)-knockout mice compared
with WT C57BL/6NTac control mice (n 10). (D) IL-18 measurements in serum of deficient mice on day 5 after infection. No detectable levels of IL-1 were
detected in circulation.
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dysregulated induction of propathologic cytokine levels that con-
tribute to lethality in high-dose, virulent infections (30, 38).
The recruitment of inflammatory monocytes to sites of infec-
tion is essential to control parasite growth and dissemination in
murine models of toxoplasmosis (12, 13). In rats, control of par-
asite proliferation and dissemination in vivo is controlled by the
Toxo1 locus (40). Our recent work showed that macrophages
from Toxoplasma-resistant rat strains (e.g., LEW and SHR) un-
dergo pyroptosis in response to inflammasome activation induced
by parasite infection, and this rapid cell death is sufficient to limit
parasite replication and promote sterile cure (66). In previous
work by Miao et al., caspase-1-induced pyroptotic cell death was
also identified as an innate immune mechanism to protect against
intracellular pathogen infection (41). In their study, the authors
used a panel of mouse strains deficient in IL-1, IL-18, IL-1R, or
various combinations of those to show a dispensable role for
IL-1 and IL-18 in the clearance of Salmonella enterica serovar
Typhimurium that expresses flagellin, suggesting that innate con-
trol of bacterial infection is occurring by pyroptosis, without a
requirement to induce an overt inflammatory response. In this
study, we show that in vitro Toxoplasma infection of murine bone
marrow-derived macrophages primarily activates the NLRP3 in-
flammasome, resulting in the rapid production and cleavage of
IL-1, but does not induce pyroptosis. Interestingly, although
Toxoplasma-infected macrophages showed efficient caspase-1/11-
dependent IL-1 cleavage and secretion, these cells did not up-
regulate, cleave, or secrete their preexisting pools of IL-18. Fur-
thermore, splenocytes also did not show any IL-18 cleavage
following infection. Paradoxically, significant concentrations of
IL-1 were not detected following infection in any mouse strain,
whereas high levels of IL-18 were found in serum in all infection
studies that we performed with different Toxoplasma strains. Be-
cause activation of the murine inflammasome does not affectTox-
oplasma growth in macrophages (data not shown) and does not
induce pyroptosis, our results suggest that IL-18 activation and
not pyroptosis is the genetic basis for in vivo inflammasome-
mediated control of parasite proliferation. Although the in vivo
cellular source for this inflammasome-generated IL-18 is not
known, it is likely of nonmyeloid origin, and bone marrow chi-
mera studies should be performed to address this question. Our
FIG 5 Parasite load, survival, and systemic IL-18 levels in IL-18- and IL-18R-knockout mice. (A) Bioluminescence imaging of 76K GFP-LUC-infected mice
(various strains, 10,000 tachyzoites, i.p. route) on days 4 to 7 following infection is shown. Images shown are 2 to 3 representative mice from 3 to 6 mice/group.
The experiment shown is one of 2 IL-1, 4 IL-18, or 4 IL-18R independent experiments. (B)P values (t test) comparing luciferase activity for each knockout strain
to C57BL/6J are 0.05. (C) Aggregate survival curve of IL-1R (n  9)-, IL-18 (n  19)-, and IL-18R (n  13)-knockout mice compared with WT C57BL/6J
control mice (n 13). (D) IL-18 measurements in serum of deficient mice on day 5 after infection. No detectable levels of IL-1 were detected in circulation.
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results also suggest that NLRP1-mediated events may be more
important in vivo and that activation of NLRP1 may likewise oc-
cur in cells other than macrophages.
The role of inflammasome activation in the pathogenesis of
Toxoplasma infection in human infection has recently been sug-
gested (16, 17). Polymorphisms in the human NLRP1 gene are
associated with susceptibility to congenital toxoplasmosis, and
NLRP1 contributes to controlling parasite growth in human
monocytes. A recent study in human macrophages provides com-
pelling evidence that the inflammasome components ASC and
caspase-1 regulate the release of IL-1 and that the type II allele of
the parasite dense granule protein GRA15, which activates NF-B
nuclear translocation, is necessary for maximal induction of this
cytokine (18). Indeed, our in vitro infection data show that Toxo-
plasma murine inflammasome-mediated secretion of IL-1 is
strain dependent and that only parasites expressing the GRA15
type II allele, which directly activates NF-B, were able to induce
secretion of IL-1 in unprimed BMDMs (Fig. 1). While the rela-
tive and contributing roles of IL-1 compared to IL-18 remain to
be determined in the control of acute toxoplasmosis, our prelim-
inary studies using IL-1 receptor-knockout mice on a mixed back-
ground argue that IL-1 plays a less significant role in the control
of parasite infection than it does in IL-18 or IL-18R knockouts
(Fig. 5) In vivo administration of IL-1 in LPS-primed caspase-1/
11-deficient mice has previously been shown to increase IL-6 (34),
so it is conceivable that IL-1 functions locally to induce increased
levels of IL-6 capable of altering inflammation-induced changes in
myeloid output that impact Toxoplasma pathogenesis (42).
Of the two NLR inflammasomes activated, we found that mu-
rine resistance to acute infection was principally dependent on
activation of the NLRP3 receptor both in vitro (Fig. 1J) and in vivo
(Fig. 3). Several reports have linked P2X(7) receptor, a potent
activator of the NLRP3 inflammasome, with control of acute tox-
oplasmosis (16, 19, 43, 44). How and in what cell type Toxoplasma
activates the murine NLRP3 inflammasome or why its activation
does not lead to rapid macrophage death or IL-18 processing is
enigmatic. Regulators of the NLRP3 inflammasome include ATP,
the guanylate-binding protein 5 (GBP5), cellular stresses that alter
calcium and potassium concentrations, redox status, and the un-
folded protein response (UPR) (for a review, see reference 45).
Importantly, Toxoplasma encodes a variety of virulence effector
proteins that specifically inactivate the host endoplasmic reticu-
lum (ER)-bound transcription factor ATF6 and induction of the
UPR during ER stress (46), affect the recruitment of 65-kDa
guanylate-binding proteins (GBPs) (47, 48), or alter calcium and
potassium efflux to signal Toxoplasma egress (49), perhaps indi-
cating that the parasite has specifically evolved effector proteins to
minimize NLR inflammasome activation to alter its pathogenesis.
Our work also identified Toxoplasma as the second pathogen,
after B. anthracis, whose pathogenesis is altered by expression of
the murine NLRP1 inflammasome (15). We show that the Nlrp1
locus is capable of regulating parasite proliferation in vivo, with
Nlrp1 knockout mice possessing significantly higher parasite bur-
dens following Toxoplasma infection. Although the majority of
NLRP1-deficient mice died acutely (Fig. 4), they were, however,
less susceptible to infection than were caspase-1/11-, Asc-, Nlrp3-,
IL-18-, or IL-18R-deficient mice in the same genetic background
and possessed only 5- to 10-fold-higher parasite loads than in WT
infections. How Toxoplasma activates the NLRP1 inflammasome
is unclear. Activation of rodent NLRP1 inflammasomes by the
B. anthracis lethal toxin (LT) occurs via proteolytic cleavage at a
specific consensus sequence in the polymorphic N terminus of
NLRP1 (50, 51). In human infection, NLRP1 polymorphism vari-
ants are likewise known to alter the susceptibility to congenital
toxoplasmosis (17). One logical hypothesis is that the
Toxoplasma-encoded effector molecule responsible for activation
of NLRP1 is, like LT, a protease. Toxoplasma secretes a wide range
of proteases (52–57), and similar induction of IL-1 observed
upon infection of primed BMDMs with any Toxoplasma strain
suggests that the putative protease, or factor responsible for acti-
vation of NLRP1, is not likely to beToxoplasma strain specific or is
at least conserved among the majority of strains. Alternatively,
polymorphisms in Nlrp1 could affect the interaction with a differ-
ent host “sensor” protein that serves as the adaptor for assembly
and activation of the NLRP1 inflammasome, as has been previ-
ously described for the NLRC4/NAIP5/NAIP6 inflammasome
recognition of flagellin (58, 59).
In summary, we establish that both NLRP3 and NLRP1 are
important in vivo regulators of Toxoplasma proliferation and that
IL-18 signaling is required to mediate host resistance to acute
toxoplasmosis. Our findings also indicate that innate resistance to
acute toxoplasmosis is dependent on the activation of both TLR
and NLR sensors that cooperate to detect the presence of pathogen
products or the danger signals that they induce during active in-
fection. The identification of the Toxoplasma factor that mediates
NLR inflammasome activation may contribute new insight into
the development of therapeutic options to combat this important
human pathogen.
MATERIALS AND METHODS
Ethics statement. All animal experiments were performed in strict accor-
dance with guidelines from the NIH and the Animal Welfare Act, under
protocols approved by the Animal Care and Use Committee of the Na-
tional Institute of Allergy and Infectious Diseases, National Institutes of
Health (protocols LPD-8E and LPD-22E), and the MIT Committee on
Animal 441 Care (assurance number A-3125-01).
Material. Ultrapure LPS was purchased from Calbiochem/EMD Bio-
sciences (San Diego, CA). Luciferin was purchased from Caliper Life Sci-
ences (Hopkinton, MA). Nigericin was purchased from Invivogen (San
Diego, CA). Mycalolide B was purchased from Wako (Richmond, VA).
Mice andNLRP1 expression status-based nomenclature. IL-18- and
IL-18 receptor (IL-18R)-knockout mice on the C57BL/6J background
(10 backcrosses) and IL-1R-deficient mice on a partially backcrossed
129 	 C57BL/6J background were obtained from Jackson Laboratories
(Bar Harbor, ME). Caspase-1-knockout mice have been previously de-
scribed (60) and were backcrossed to C57BL/6NTac mice for 10 genera-
tions. These caspase-1-knockout mice are also deficient in caspase-11
(26). Mice deleted for all three Nlrp1 genes in the murine Nlrp1abc locus
(C57BL/NTac background), as well as those deleted only for Nlrp1b
(C57BL/6J background), have been previously described (61, 62). Mice
deleted at Nlrp3 (C57BL/6J background) (63) and Asc (C57BL/6J back-
ground) (60) have been previously described.
Parasites. Tachyzoites from luciferase-expressing type I (RH) and
type II (76K or Prugniaud) T. gondii parasites were used for all studies.
The following strains (haplogroup/type in parentheses) were used in a
survey of effects on murine BMDMs: GT1 (I), ME49 (II), DEG (II), CEP
(III), VEG (III), CASTELLS (IV), MAS (IV), GUY-KOE (V), GUY-MAT
(V), RUB (V), BOF (VI), GPHT (VI), CAST (VII), TgCATBr5 (VIII), P89
(IX), GUY-DOS (X), VAND (X), Cougar (XI), B41 (XII), B73 (XII), RAY
(XII), and WTD3 (XII). The generation of luciferase-expressing parasites
using the plasmid pDHFR-Luc-GFP gene cassette has been described pre-
viously (64). To construct the RH, Prugniaud, and 76K GFP-LUC strains,
pDHFR-Luc-GFP was linearized with NotI, parasites were electroporated,
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and those with stable GFP expression were isolated by fluorescence-
activated cell sorting and cloned by limiting dilution. Generation of Pru
GRA15-knockout (KO) parasites has been previously described (24). All
parasite strains were routinely passaged in vitro in monolayers of human
foreskin fibroblasts (HFFs) at 37°C in the presence of 5% CO2 and quan-
tified by hemocytometer counts prior to infection studies. In some exper-
iments, mycalolide B (3 M, 20 min) was used to pretreat isolated para-
sites prior to washing in phosphate-buffered saline (PBS) (3	) before
infections.
Cell culture.Bone marrow-derived macrophages (BMDMs) were cul-
tured in complete Dulbecco’s modified Eagle’s medium (DMEM) with
20% L929 cell culture supernatant for 7 days. L929 mouse fibroblast cells
were grown in DMEM supplemented with 10% fetal bovine serum,
10 mM HEPES, and 50 g/ml gentamicin (all obtained from Invitrogen,
Carlsbad, CA) at 37°C in 5% CO2. BMDMs with or without LPS priming
(0.1g/ml, 2 h) were infected withToxoplasma at various multiplicities of
infection (MOIs), and cell viability was assessed at 24 h using the CellTiter
96 AQueous One Solution cell proliferation assay (Promega, Madison,
WI). Culture supernatants were removed for cytokine measurements by
enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneap-
olis, MN) or Western blotting, following concentration using Amicon
filters (3,000-molecular-weight cutoff) (Millipore, Billerica, MA) or
Spin-X UF 500 concentrators (5,000-molecular-weight cutoff) (Corning,
United Kingdom). For Western blots, anti-mouse IL-1 (Abcam, Cam-
bridge, MA) or anti-caspase-1 antibody (Abcam, Cambridge, MA) was
used as the primary antibody. Secondary antibodies were from Jackson
Immunoresearch (West Grove, PA). Immun-Star Western C substrate
(Bio-Rad, Hercules, CA) and a charge-coupled device camera (Chemidoc
XRS; Bio-Rad) were used for visualization. All immortalized macrophage
cell lines (WT and caspase-1/11/) were grown in complete DMEM with
10% L929-conditioned medium.
Microarray analysis. Microarray analyses were performed as previ-
ously described (65).
Mouse infections. Mice (male and female, 8 to 12 weeks old) were
infected intraperitoneally (i.p.) with either 10,000 (76K) or 1,200 (Pru)
type II tachyzoites diluted in 400 l of phosphate-buffered saline. Mice
were imaged on successive days (typically days 4 to 9) postinfection, and
parasite burden was quantified by firefly luciferase activity using an IVIS
BLI system from Caliper Life Sciences. Mice were injected i.p. with 3 mg of
D-luciferin substrate (prepared in 200l of PBS) and imaged for 5 min to
detect photons emitted, as previously described (64). Mice were bled by
tail vein at day 5 and/or day 9 after infection. Blood collection was per-
formed in either serum collector or Microtainer EDTA tubes (Sarstedt,
Newton, NC). IL-1 and IL-18 were measured by ELISA (R&D Systems,
Minneapolis, MN).
SUPPLEMENTAL MATERIAL
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